(September 28, 2022, 12:22 PM EDT) -- BOSTON — A Massachusetts federal judge gave final approval to a previously disclosed $900 million settlement by Biogen Inc. of a whistleblower lawsuit alleging the pharmaceutical company paid kickbacks to induce doctors to prescribe three of the defendant’s multiple sclerosis (MS) drugs....